Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOBI: CCH-aaes Bruising Mitigation Study
NCT04677712Phase 4Completed
- Sponsor
- Endo International plc
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Started Dec 2020; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT04677712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04677712.